Lemaitre Vascular (LMAT) Operating Leases (2019 - 2026)

Lemaitre Vascular (LMAT) has 8 years of Operating Leases data on file, last reported at $20.9 million in Q1 2026.

• On a quarterly basis, Operating Leases rose 42.1% year-over-year to $20.9 million in Q1 2026; TTM through Mar 2026 was $20.9 million, a 42.1% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, down 8.07% from the prior year.
• Operating Leases for Q1 2026 stood at $20.9 million, up from $14.0 million in the prior quarter.
• Over the last five years, Operating Leases for LMAT reached as high as $20.9 million in Q1 2026 and fell as low as $13.7 million in Q1 2022.
• Historically, Operating Leases has averaged $16.1 million across 5 years, with a median of $15.4 million in 2022.
• Across the five-year window, Operating Leases declined 19.31% in 2025 and soared 42.1% in 2026, its largest moves.
• Year by year, Operating Leases stood at $14.7 million in 2022, then increased by 13.01% to $16.6 million in 2023, then decreased by 8.37% to $15.2 million in 2024, then slipped by 8.07% to $14.0 million in 2025, then jumped by 49.6% to $20.9 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $20.9 million in Q1 2026, $14.0 million in Q4 2025, and $17.2 million in Q3 2025.